NTLA-2001
regeneron,Intellia Therapeutics
['cardio', 'regeneron', 'crispr']
icymi: in a first-in-human study, the researchers evaluated ntla-2001 (intellia/regeneron), a novel crispr/cas9-based in vivo gene editing therapy #aha22 #cardiotwitter 
The content you need, when you need it.